Literature DB >> 35094397

Serious health threat of mucormycosis during the ongoing COVID-19 pandemic: what dermatologists need to know in this regard.

Parvaneh Hatami1, Kamran Balighi1,2, Hamed Nicknam Asl3, Zeinab Aryanian1,4.   

Abstract

BACKGROUND: Recently, a surge of mucormycosis in patients affected with or recovered from SARS-Cov-2 has been noted, especially in developing countries such as India, Pakistan, and Iran. AIM: To focus on existing data about the important aspects of COVID-associated mucormycosis.
METHODS: We searched on PubMed, Google Scholar, and Scopus in this regard, and all of the relevant papers published until August 28, 2021, for which we could access their full-texts, were included.
RESULTS: We found some recommendations made by ophthalmologists, anesthesiologists, and ENT surgeons and tried to summarize them to provide a practical guide for dermatologists.
CONCLUSION: Careful examination and clinical suspicion are the key factors for correct diagnosis especially in patients affected by or recently recovered from COVID. Implementing some preventive measures such as using a titrated dose of corticosteroids and encouraging patients to get vaccinated should be considered to tackling this serious issue.
© 2022 the International Society of Dermatology.

Entities:  

Mesh:

Year:  2022        PMID: 35094397     DOI: 10.1111/ijd.16101

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   3.204


  5 in total

1.  New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.

Authors:  Fatemeh Mohaghegh; Parvaneh Hatami; Arezoo Refaghat; Mohammadjavad Mehdizadeh; Zeinab Aryanian; Nessa Aghazadeh Mohandesi; Zeinab Mohseni Afshar
Journal:  Clin Case Rep       Date:  2022-06-03

2.  Morphea in two patients after being infected to and being vaccinated against SARS-CoV-2 infection.

Authors:  Zeinab Aryanian; Kamran Balighi; Parvaneh Hatami; Nasim Mazloumi Tootoonchi; Azadeh Goodarzi; Zeinab Mohseni Afshar
Journal:  Clin Case Rep       Date:  2022-04-18

Review 3.  The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.

Authors:  Zeinab Aryanian; Kamran Balighi; Parvaneh Hatami; Zeinab Mohseni Afshar; Nessa Aghazadeh Mohandesi
Journal:  Dermatol Ther       Date:  2022-04-01       Impact factor: 3.858

Review 4.  SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.

Authors:  Zeinab Aryanian; Kamran Balighi; Parvaneh Hatami; Azadeh Goodarzi; Nessa Aghazadeh Mohandesi; Zeinab Mohseni Afshar
Journal:  Dermatol Ther       Date:  2022-03-22       Impact factor: 3.858

5.  Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis.

Authors:  Abdul Arif Khan; Sudhir K Jain; Mahendra Rai; Samiran Panda
Journal:  Comput Struct Biotechnol J       Date:  2022-08-10       Impact factor: 6.155

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.